Valeant Pharmaceuticals International (VRX) Completes Tender Offer for Obagi Medical Products, Inc. (OMPI)
4/25/2013 11:21:05 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc. (OMPI)
4/25/2013 9:11:49 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for Its Previously Announced Acquisition of Obagi Medical Products, Inc. (OMPI)
4/24/2013 10:09:22 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces Receipt of Antitrust Clearance in the United States for Its Previously Announced Acquisition of Obagi Medical Products, Inc. (OMPI)
4/22/2013 11:01:56 AM
More...
|
Merz Pharma Group Declines to Raise Bid for Obagi Medical Products, Inc. (OMPI), Yielding to Valeant Pharmaceuticals International (VRX)
4/8/2013 7:53:27 AM
More...
|
Valeant Pharmaceuticals International (VRX) and Obagi Medical Products, Inc. (OMPI) Agree on an Increased Offer Price of $24.00 Per Share in Cash
4/3/2013 11:40:34 AM
More...
|
Merz Pharma Group Offers $383.5 Million for Obagi Medical Products, Inc. (OMPI), Tops Deal Announced Last Month With Valeant Pharmaceuticals International (VRX)
4/2/2013 7:32:19 AM
More...
|
Valeant Pharmaceuticals International (VRX) Agrees to Acquire Obagi Medical Products, Inc. (OMPI) for $344 Million
3/20/2013 7:28:40 AM
More...
|
Obagi Medical Products, Inc. (OMPI) Reports Fourth Quarter and Year-End 2012 Financial Results
3/15/2013 6:26:48 AM
More...
|
Obagi Medical Products, Inc. (OMPI) to Report Fourth Quarter and Year End 2012 Financial Results and Host a Conference Call on March 14
2/22/2013 6:59:43 AM
More...
|
|